Risk of extra-intestinal cancer in inflammatory bowel disease: Meta-analysis of population-based cohort studies

American Journal of Gastroenterology

Volumn 105, Issue 7, 2010, Pages 1480-1487

  Pedersen, Natalia ^a   Duricova, Dana ^b   Elkjaer, Margarita ^a   Gamborg, Michael ^c   Munkholm, Pia ^a   Jess, Tine ^c  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b CHARLES UNIVERSITY   (Czech Republic)

^c The Capital Region   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BILE DUCT CANCER; BLADDER; BLADDER CANCER; BREAST CANCER; CANCER RISK; COHORT ANALYSIS; COMPUTER PROGRAM; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; EXTRA INTESTINAL CANCER; HUMAN; INCIDENCE; INTESTINE CANCER; KIDNEY CANCER; LEUKEMIA; LIVER CANCER; LUNG CANCER; LYMPHOMA; MEDLINE; MELANOMA; NONHODGKIN LYMPHOMA; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RESPIRATORY TRACT CANCER; REVIEW; SKIN; SKIN CANCER; SYSTEMATIC REVIEW; ULCERATIVE COLITIS; UPPER GASTROINTESTINAL TRACT; UTERINE CERVIX CANCER;

CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; COLITIS, ULCERATIVE; CONFIDENCE INTERVALS; CROHN DISEASE; DIGESTIVE SYSTEM NEOPLASMS; HUMANS; INCIDENCE; LEUKEMIA; LUNG NEOPLASMS; NEOPLASMS; PREVALENCE; RISK; URINARY BLADDER NEOPLASMS;

EID: 77954426269     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.760     Document Type: Review

References (34)

1. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: A meta-analysis. Gut 2001;48:526-535
2. Jess T, Gamborg M, Matzen P et al. Increased risk of intestinal cancer in Crohn's disease: A meta-analysis of population-based cohort studies. Am J Gastroenterol 2005;100:2724-2729
3. Langholz E, Munkholm P, N ielsen O H et al. Incidence and prevalence of ulcerative colitis in Copenhagen county from 1962 to 1987. Scand J Gastroenterol 1991;26:1247-1256
4. Munkholm P, Langholz E, N ielsen O H et al. Incidence and prevalence of Crohn's disease in the county of Copenhagen, 1962-1987: A sixfold increase in incidence. Scand J Gastroenterol 1992;27:609-614
5. Munkholm P. Crohn's disease-occurrence, course and prognosis. An epidemiologic cohort-study. Dan Med Bull 1997;44:287-302. (Pubitemid 27293419)
6. Shivananda S, Lennard -Jones J, Logan R et al. Incidenceofinf ammatory bowel disease across Europe:is there a dif erence between north and south? Results of the European Collaborative Study on Inf ammatory Bowel Disease (EC-IBD). Gut 1996;39:690-697
7. Vind I, Riis L, Jess T et al. Increasing incidences of inf ammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: A population-based study from the Danish Crohn colitis database. Am J Gastroenterol 2006;101:1274-
8. von Roon A C, R eese G, T eare J et al.The risk of cancer in patients with Crohn's disease. Dis Colon Rectum 2007;50:839-855
9. Badassano R N, Piccoli D A. In f ammatory bowel disease in pediatric and adolescent patients. Gastroenterol Clin North Am 1999;28:445-458
10. Caprilli R, Gassull M A, Escher JC et al. European evidence based consensus on the diagnosis and management of Crohn's disease:special situations. Gut 2006;55 (Suppl 1):i36-58.
11. Lennard-Jones J. Classification of infammatory bowel disease. Scand J Gastroenterol 1989:(Suppl 170):2-6.
12. Bernstein C N, Blanchard JF, Kliewer E et al. Cancer riskinpatients with inf ammatory bowel disease: A population-based study. Cancer 2001; 91:854-862
13. Ekbom A, Helmick C, Zack M et al. Extracolonic malignancies in inf am mator y bowel disease. Cancer 1991; 67:2015-2019
14. Jess T, Winther K V, Munkholm P et al. Intestinal and extra-intestinal cancer in Crohn's disease:follow-up of a population-based cohort in Copenhagen County, Denmark. Aliment Pharmacol Ther 2004;19:287-293
15. Karlen P, Loferg R, Brostrom O et al. Increased risk of cancer in ulcerative colitis: A population-based cohort study. Am J Gastroenterol 1999;94:1047-1052
16. Katsanos K H, Vermeire S, Christodoulou D K et al. Dysplasia and cancer in inf ammatory bowel disease 10 years after diagnosis:results of a population-based European collaborative follow-up study. Digestion 2007; 75:113-121
17. Lofus E V Jr, Tremaine W J, Habermann T M et al. Risk of lymphoma in infammatory bowel disease. Am J Gastroenterol 2000;95:2308-2312
18. Palli D, Trallori G, Bagnoli S et al. Hodgkin's disease risk is increased in patients with ulcerative colitis. Gastroenterology 2000; 119:647-653
19. Persson P G, Karlen P, Bernell O et al. Crohn's disease and cancer: A population- based cohort study. Gastroenterology 1994; 107:1675-1679
20. Askling J, Brandt L, Lapidus A et al. Risk of haematopoietic cancer in patients with inf ammatory bowel disease. Gut 2005; 54:617-622
21. Ekbom A, Helmick C, Zack M et al. The epidemiology of inf ammatory bowel disease: A large, population-based study in Sweden. Gastroenterology 1991;100:350-358
22. Haldane J B. The estimation and signif cance of the logarithm of a ratio of frequencies. Ann Hum Genet 1956;20:309-311
23. Bofetta P. Tobacco smoking and risk of bladder cancer. Scand J Urol Nephrol Suppl 2008;218:45-54.
24. Lakatos P L, Szamosi T, Lakatos L. Smoking in infammatory bowel diseases:good, bad or ugly? World J Gastroenterol 2007;13:6134-6139
25. Parrish JA. Immunosuppression, skin cancer, and ultraviolet A radiation. N Engl J Med 2005;353:2712-2713
26. Cooke M S, Duarte T L, Cooper D et al. Combination of azathioprine and U VA irradiation is a major source of cellular 8-oxo-7,8-dihydro-2 ' - deoxyguanosine. DNA Repair (Amst) 2008; 7:1982-1989
27. Lofus E V Jr, Harewood G C, Lofus C G et al.PSC-IBD:aunique form of inf ammatory bowel disease associated with primary sclerosing cholangitis. Gut 2005;54:91-96
28. Saich R, Chapman R. Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inf ammatory bowel disease. World J Gastroenterol 2008;14:331-337
29. Claessen M M, Vleg gaar F P, Tytgat K M et al. High lifetime risk of cancer in primary sclerosing cholangitis. J Hepatol 2009;50:158-164
30. Birrenbach T, Bocker U. I n f ammatory bowel disease and smoking: A review of epidemiology, pathophysiology, and therapeutic implications. Inf amm Bowel Dis 2004;10:848-859
31. Mahid SS, Minor KS, Soto RE et al. Smoking and inf ammatory bowel disease: A meta-analysis. Mayo Clin Proc 2006;81:1462-1471
32. Jess T, Gamborg M, Munkholm P et al. Overall and cause-specific mortality in ulcerative colitis:meta-analysis of population-based inception cohort studies. Am J Gastroenterol 2007; 102:609-617
33. Lewis J D, Bilker W B, Brensinger C et al. In f ammatory bowel disease is not associated with an increased risk of lymphoma. Gastroenterology 2001;121:1080-1087
34. Jones JL, Lofus E V Jr. Lymphom a risk in in f ammatory bowel disease:is it the disease or its treatment? Infamm Bowel Dis 2007;13:1299-1307